Roche has reported mid-stage results that put its lead obesity candidate closer to the front of a fast-moving race dominated by Eli Lilly and Novo Nordisk. The Swiss group said its once-weekly injectable Roche CT-388 obesity drug achieved up to 22.5% placebo-adjusted...
The pharmaceutical industry is bracing for a significant financial blow. Analysts forecast costs of between $13 billion and $19 billion following a new transatlantic trade deal. This deal will subject branded medicines to a hefty 15% tariff. Officials confirmed the...
Ground-breaking advancements in immunotherapy are poised to transform cancer care. New data reveal the effectiveness of these immune-boosting drugs in treating a wider range of cancers at their earlier stages. Previously established as life-extending treatments for...
Roche has filed a lawsuit in the California federal court against Stanford University and medical technology startup Foresight Diagnostics, alleging that Foresight misappropriated its genetic-sequencing trade secrets to develop competing cancer-detection products. In...
